360head Stockiq
Global Intelligence Terminal
Loading live prices…
LIVE
--:--:--
AI-generated, informational and educational only. Not financial advice. Past performance does not indicate future results. Always do your own research.

Arrowhead Pharmaceuticals Inc (ARWR)

A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.

Biotechnology· US· arrowheadpharma.com
Trade ARWR on Webull →
0/100
Low signalSIGNAL SCORE
P(beat S&P 500 · next 20 sessions)42%

⚠ Earnings on 2026-11-30, inside this window. Results around earnings are less predictable. Also measured against its sector ETF (XBI).

Our last 30 days of resolved calls came true 18% of the time.See the track record →

Price
$47.78
1 day
+1.34%
1 week
-18.93%
Month to date
-21.29%
1 year
+13.83%
Market cap
$6.7B
Company fundamentals
EPS (TTM)
$-5.07
Debt / Equity
25.43
Current ratio
4.14
Operating margin
-156.9%
Net margin
-160.6%
Gross margin
95.2%
Return on equity
-170.6%
Revenue growth (YoY)
-45.6%

Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.

Example trade plan · illustrative risk framework
Entry zone
$47.06–$48.74
Stop-loss (exit)
$43.00 −10%
Target (exit)
$57.34 +20%

A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.

Why it ranks: factor attribution

Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →

Why it's moving: recent catalysts

🤖 Dominant catalyst is product-related, driven by upcoming clinical data presentations. Continuation probability is moderate, as technical momentum supports the move but data readouts carry inherent uncertainty. Informational only — not financial advice.

Any AI summary is an interpretation of public news, not advice or a price target.

ARWR Signal Score & analysis · 360head Stockiq